Unlock instant, AI-driven research and patent intelligence for your innovation.

4,5-disubstituted thiazole derivative, preparation method and use thereof

A di-substituted and mono-substituted technology, applied in the field of diabetes-related drugs, can solve problems such as undiscovered weight gain

Inactive Publication Date: 2009-10-07
天津天诚新药评价有限公司
View PDF1 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Clinical results show that this type of drug has a good hypoglycemic effect, and no adverse reactions such as weight gain and hypoglycemia, which are common in other diabetes drugs, have been found

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 4,5-disubstituted thiazole derivative, preparation method and use thereof
  • 4,5-disubstituted thiazole derivative, preparation method and use thereof
  • 4,5-disubstituted thiazole derivative, preparation method and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] 5-Bromo-2-(2-chloroacetyl)aminothiazole (III-1)

[0037]

[0038] In a 100mL round bottom flask, add 1.79g (10mmol) compound II-1, 1.01g (13mmol) dry triethylamine and 50mL dry CH 2 Cl 2 , the mixture was cooled with an ice-water bath under stirring, and then slowly added dropwise 1.24 g (11 mmol) of chloroacetyl chloride dissolved in 5 mL of dry CH 2 Cl 2 After the resulting solution was added dropwise, the reaction mixture was stirred at room temperature for 1 hour. The reaction mixture was washed with 50 mL CH 2 Cl 2 After dilution, it was washed with saturated brine, and the organic phase was washed with anhydrous Na 2 SO 4 After drying, the solvent was removed on a rotary evaporator, and the obtained residue was purified by column chromatography to obtain a pure product of compound III-1, 2.30 g, with a yield of 90%. Colorless crystal, melting point 203-204°C, 1 H NMR (DMSO-d 6, 400MHz), δ12.74(s, 1H), 7.60(s, 1H), 4.40(s, 2H).

[0039] Compounds II-1 ...

Embodiment 2

[0041] 5-Bromo-2-(2-chloroacetyl)amino-4-methylthiazole (III-2)

[0042]

[0043] In a 100mL round bottom flask, add 1.93g (10mmol) compound II-2, 1.07g (13mmol) dry 2,6-lutidine and 50mL dry CH 2 Cl 2 , the mixture was cooled with an ice-water bath under stirring, and then slowly added dropwise 1.24 g (11 mmol) of chloroacetyl chloride dissolved in 5 mL of dry CH 2 Cl 2 After the resulting solution was added dropwise, the reaction mixture was stirred at room temperature for 1 hour. The reaction mixture was washed with 50 mL CH 2 Cl 2 After dilution, it was washed with saturated brine, and the organic phase was washed with anhydrous Na 2 SO 4 After drying, the solvent was removed on a rotary evaporator, and the obtained residue was purified by column chromatography to obtain a pure product of compound III-2, 2.45 g, with a yield of 91%. Colorless crystals, IR(KBr), 3332, 1690cm -1 .

[0044] Compounds II-2 and III-2 are one of the compounds having the general formu...

Embodiment 3

[0046] 2-(2-Chloroacetyl)amino-5-methylthiazole (III-3)

[0047]

[0048] In a 100mL round bottom flask, add 1.14g (10mmol) compound II-3, 1.03g (13mmol) dry pyridine and 50mL dry CH 2 Cl 2 , the mixture was cooled with an ice-water bath under stirring, and then slowly added dropwise 1.24 g (11 mmol) of chloroacetyl chloride dissolved in 5 mL of dry CH 2 Cl 2 After the resulting solution was added dropwise, the reaction mixture was stirred at room temperature for 1 hour. The reaction mixture was washed with 50 mL CH 2 Cl 2 After dilution, it was washed with saturated brine, and the organic phase was washed with anhydrous Na 2 SO 4 After drying, the solvent was removed on a rotary evaporator, and the obtained residue was purified by column chromatography to obtain the pure product of compound III-3, 1.79 g, with a yield of 94%. Colorless crystals, melting point 96-98°C, 1 H NMR (DMSO-d 6 , 400MHz), δ6.58 (bs, 2H, NH 2 ), 6.556-6.559 (d, 1H, J=1.2Hz, Ar-H), 2.16-2.1...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
Login to View More

Abstract

The invention relates to a diabetes-related medicine field. Concretely, the invention relates to a dipeptidyl peptidase-IV inhibitor containing 4,5-disubstituted thiazole structure of general formula I with therapeutic action on diabetes and its preparation method, medicine combination containing the same, and its use in preparing medicine for treating diabetes. The groups are defined in the specification.

Description

technical field [0001] The invention relates to the field of medicine related to diabetes. Specifically, the present invention relates to a dipeptidyl peptidase-IV inhibitor containing a 4,5-disubstituted thiazole structure, a preparation method thereof, and a pharmaceutical composition containing the same for diabetes. Background technique [0002] According to statistics, there were approximately 250 million diabetic patients in the world in 2007, most of whom were type II (ie, non-insulin-dependent) diabetic patients. The antidiabetic drugs currently in clinical use mainly include sulfonylureas, metformin and insulin drugs. In recent years, insulin sensitizers and α-glucosidase inhibitors have also been marketed. These drugs have good therapeutic effects, but severe side effects such as hypoglycemia are common, and there are safety problems in long-term treatment, such as liver toxicity and weight gain. [0003] Dipeptidyl peptidase IV (dipeptidyl peptidase IV, DPP-IV) ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D277/46C07D417/12C07D277/58A61K31/426A61K31/427A61P3/10
Inventor 赵桂龙徐为人王玉丽汤立达战付旭刘巍谭初兵张士俊刘冰妮李祎亮邹美香
Owner 天津天诚新药评价有限公司